NCT02150070View on ClinicalTrials.gov

A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Pharmacokinetics of ASP2408Healthy Subjects
Interventions
DRUG

ASP2408

Intravenous (IV) infusion and subcutaneous (SC) injection

DRUG

Placebo

Intravenous (IV) infusion and Subcutaneous (SC) injection

Trial Locations (1)

21225

Parexel International, Baltimore

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT02150070 - A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections | Biotech Hunter | Biotech Hunter